TY  - JOUR 
AU  - Londono, Maria-Carlota
AU  - Riveiro-Barciela, Mar
AU  - Ahumada, Adriana
AU  - Munoz-Gomez, Raquel
AU  - Roget, Merce
AU  - Devesa-Medina, Maria J
AU  - Serra, Miguel Angel
AU  - Navascues, Carmen A
AU  - Baliellas, Carme
AU  - Aldamiz-Echevarria, Teresa
AU  - Gutierrez, Maria L
AU  - Polo-Lorduy, Benjamin
AU  - Carmona, Isabel
AU  - Benlloch, Salvador
AU  - Bonet, Lucia
AU  - Garcia-Samaniego, Javier
AU  - Jimenez-Perez, Miguel
AU  - Moran-Sanchez, Senador
AU  - Castro Iglesias, Angeles
AU  - Delgado Blanco, Manuel
AU  - Gea-Rodriguez, Francisco
AU  - Martín-Granizo Barrenechea, Ignacio
AU  - Montes, Maria Luisa
AU  - Morano Amado, Luis
AU  - Castano, Manuel A
AU  - de Los Santos, Ignacio
AU  - Laguno, Montserrat
AU  - Losa, Juan Emilio
AU  - Montero-Alonso, Marta
AU  - Rivero, Antonio
AU  - de Alvaro, Cristina
AU  - Manzanares, Amanda
AU  - Mallolas, Josep
AU  - Barril, Guillermina
AU  - Gonzalez-Parra, Emilio
AU  - Garcia-Buey, Luisa
PY  - 2019
SN  - 1932-6203
UR  - http://hdl.handle.net/20.500.11940/15905
AB  - BACKGROUND AND AIMS: Limited data are available on the effectiveness and tolerability of direct-acting antivirals (DAAs) therapies in the real world for HCV-infected patients with comorbidities. This study aimed to describe the effectiveness of...
LA  - eng
KW  - Drug Therapy
KW  - Middle Aged
KW  - Ribavirin
KW  - Sulfonamides
KW  - Coinfection
KW  - Ritonavir
KW  - Genotype
KW  - Carbamates
KW  - Hepatitis C
KW  - Renal Insufficiency
KW  - Humans
KW  - Treatment Outcome
KW  - Uracil
KW  - Anilides
KW  - Macrocyclic Compounds
KW  - Hepacivirus
KW  - Renal Dialysis
KW  - Retrospective Studies
KW  - Aged
KW  - Antiviral Agents
KW  - HIV Infections
TI  - Effectiveness, safety/tolerability of OBV/PTV/r +/- DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study
DO  - 10.1371/journal.pone.0221567
T2  - PLoS One
KW  - CHUAC
KW  - CHUVI
VL  - 14
ER  -